Pfizer Canada Invests $750,000 in Q-CROC

PHILADELPHIA (Pennsylvania), June 3, 2019 – Pfizer Canada is proud to announce a $750,000 contribution to Q-CROC to address numerous health needs identified by the scientific community, industry partners, patients and the government. Pfizer’s financial support will assist Q-CROC in its ongoing efforts to create a group of specialist researchers and develop initiatives aimed at […]

June 3, 2019

En savoir plus

International Clinical Trials Day 2019

Did you know that May is associated with clinical research? From May 13th to 24th, more than twenty Q-CROC hospital members will hold information sessions in Quebec to inform and educate the public about the importance of clinical trials in health. Q-CROC is proud to be able to count on the support of the Ministry […]

April 30, 2019

En savoir plus

$1M to support clinical research in oncology in Quebec

Montreal, November 6, 2018 – The Quebec – Clinical Research Organization in Cancer (Q-CROC) and the Oncopole are proud to announce the creation of a partnership to support clinical research in oncology. Over the next three years, the $1M contribution made by the Oncopole will enhance the support being offered to the Quebec clinical research […]

November 6, 2018

En savoir plus

International Clinical Trials Day 2018

Would you like to know more about clinical trials? Several awareness-raising activities will take place in Quebec during the month of May, beginning with a webinar co-organized with the Canadian Cancer Society on May 10th. Q-CROC is proud to be able to count on the support of the Ministry of Economy, Science and Innovation, Pfizer […]

May 10, 2018

En savoir plus

Cancer Clinical Trials Pathway Model Consensus Meeting – June 13, 2017

Cancer clinical trials are a critical part of bringing new therapies to life. These studies are made possible by patients who agree to participate, allowing researchers to measure the effects of potentially new and better treatments that may extend a patient’s life and/or improve their quality of life. An overwhelming number of clinical trials fail […]

March 29, 2017

En savoir plus

Have you been asked to participate in a clinical trial?

  Researchers in Canada are seeking feedback on your experience with declining or participating in a clinical trial via an on-line, anonymous survey.   To access this on-line survey, please click here.   Photo courtesy of BCCRIN   Lire l’article en français >  

March 28, 2017

En savoir plus

52nd RALi

    On March 22nd, all Q-CROC liaison coordinators attended the 52nd RALi (Rencontre des agents de liaison) teleconference meeting, along with several members of the Q-CROC team.   Topics covered included the Fair Market Value Working Group that met earlier this month in Toronto (see related article), the initiative at the CHU Quebec City to centralize budget review […]

March 23, 2017

En savoir plus

CCTCC Fair Market Value (FMV) Working Group (WG)

    CCTCC Fair Market Value (FMV) Working Group (WG)   On March 6th, representatives from several healthcare institutions and pharmaceutical companies met in Toronto to take part in the Fair Market Value (FMV) initiative working group (WG), led by the Canadian Clinical Trials Coordinating Centre (CCTCC). Among the participants, Maisonneuve-Rosemont Hospital and the Center […]

March 9, 2017

En savoir plus

Dr. Normand Blais appointed to the CRCHUM’s management team

  The board of directors of the CHUM Research Centre (CRCHUM) has announced the appointment of Dr. Normand Blais as Assistant Scientific Director of Clinical Research for cancer research development.   His mandate will focus on improving quality of care and facilitating the development and integration of innovations for the benefit of patients. Q-CROC congratulates […]

March 7, 2017

En savoir plus